Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

Naber CK, Pyxaras SA, Nef H, Ijsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska J, Eberli FR, Moellmann H, Galatius S, Rieber J, Commeau P, Van Geuns RJ, Bouchez D, Mudra H (2016)


Publication Type: Journal article

Publication year: 2016

Journal

Book Volume: 12

Pages Range: 356-8

Journal Issue: 3

DOI: 10.4244/EIJY15M06_02

Abstract

AIMS: We aimed to evaluate the long-term safety and efficacy of the STENTYS self-apposing paclitaxeleluting stent (STENTYS-PES) in bifurcation lesions in routine clinical practice. METHODS AND RESULTS: The primary endpoint of the study was the composite major adverse cardiac events (MACE: cardiac death, myocardial infarction, clinically driven target lesion revascularisation, or emergent bypass surgery) assessed at six months after enrolment. This was reported in 21 patients (10.1%), mainly due to clinically driven target lesion revascularisation (TLR). At 12 months, 27 patients experienced MACE (13.0%). CONCLUSIONS: The long-term results of OPEN II show that the STENTYS-PES is safe and effective in the treatment of all-comers with coronary bifurcation lesions.

Authors with CRIS profile

Additional Organisation(s)

Involved external institutions

How to cite

APA:

Naber, C.K., Pyxaras, S.A., Nef, H., Ijsselmuiden, A.J., Briguori, C., Schlundt, C.,... Mudra, H. (2016). Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study. EuroIntervention, 12(3), 356-8. https://dx.doi.org/10.4244/EIJY15M06_02

MLA:

Naber, Christoph K., et al. "Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study." EuroIntervention 12.3 (2016): 356-8.

BibTeX: Download